Concepedia

Author

Isabel Machuca

Instituto Maimónides de Investigación Biomédica de CórdobaORCID

Also Known As

A Camacho, I Machuca, I. Machuca, Inmaculada Ruiz-Cáceres, Isabel Machuca, L F López-Cortés, Pedro López, Sandra Pérez Gómez

81

Publications

2.6K

Citations

26

H-Index

54

Concepts

All Affiliations

Instituto Maimónides de Investigación Biomédica de CórdobaHospital Universitario Reina SofíaUniversity of CórdobaHospital Universitario Virgen MacarenaUniversidad de Sevilla
IM

About

Isabel Machuca is an author at Instituto Maimónides de Investigación Biomédica de Córdoba specializing in medicine, antimicrobial resistance, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

607

2

Health Sciences

6

6

158

3

Natural Sciences

1

1

37

4

Public Health

1

1

23

5

Biochemistry

1

1

37

Isabel Machuca

×

38

Publications

1.6K

Citations

24

H-Index

YearCitations

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Elizabeth Temkin, Julián Torre‐Cisneros, Bojana Beovič,

Antimicrobial Agents and Chemotherapy

2016

250

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto,

Mayo Clinic Proceedings

2016

115

Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

Ángela Cano, Belén Gutiérrez‐Gutiérrez, Isabel Machuca,

Clinical Infectious Diseases

2017

105

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

Isabel Machuca, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger,

Antimicrobial Agents and Chemotherapy

2017

74

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron,

The Lancet HIV

2020

68

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs

Susana Araújo, Sara Bañón, Isabel Machuca,

European Journal of Endocrinology

2014

59

The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii

T. Amat, Isabel Machuca, Irene Gracia-Ahufinger,

Clinical Microbiology and Infection

2017

56

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus–Infected Patients With Nonalcoholic Fatty Liver Disease

Juan Macı́as, M.J. Mancebo, Dolores Merino,

Clinical Infectious Diseases

2017

56

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study

Tanya Babich, Pontus Nauclér, John Karlsson Valik,

International Journal of Antimicrobial Agents

2019

55

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

Zaira R. Palacios‐Baena, Belén Gutiérrez‐Gutiérrez, Esther Calbo,

Clinical Infectious Diseases

2017

54

Page 1